{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:19:18Z","timestamp":1790299158371,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012540","name":"Guangdong Innovative Research Team Program","doi-asserted-by":"publisher","award":["2009010058"],"award-info":[{"award-number":["2009010058"]}],"id":[{"id":"10.13039\/100012540","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijantimicag.2018.12.009","type":"journal-article","created":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T01:08:15Z","timestamp":1546132095000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo"],"prefix":"10.1016","volume":"53","author":[{"given":"Shinuan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfeng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-7461","authenticated-orcid":false,"given":"Xuemin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0001","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJM199909233411302","article-title":"Neurologic complications in children with enterovirus 71 infection","volume":"341","author":"Huang","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3949\/ccjm.81a.13132","article-title":"Hand, foot, and mouth disease: identifying and managing an acute viral syndrome","volume":"81","author":"Repass","year":"2014","journal-title":"Clev Clin J Med"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0003","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/JCM.43.8.3835-3839.2005","article-title":"Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China","volume":"43","author":"Li","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1423-0127-16-103","article-title":"Viral and host proteins involved in picornavirus life cycle","volume":"16","author":"Lin","year":"2009","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.coviro.2015.04.008","article-title":"Structural insights into viral IRES-dependent translation mechanisms","volume":"12","author":"Lozano","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0006","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1423-0127-21-14","article-title":"Recent developments in antiviral agents against enterovirus 71 infection","volume":"21","author":"Tan","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0007","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1515\/JBCPP.1995.6.3-4.229","article-title":"Mechanism of inhibition of protein synthesis by macrolide and lincosamide antibiotics","volume":"6","author":"Menninger","year":"1995","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0008","first-page":"1","article-title":"Immuno-modulation and anti-inflammatory benefits of antibiotics: the example of tilmicosin","volume":"74","author":"Buret","year":"2010","journal-title":"Can J Vet Res"},{"issue":"Suppl 2","key":"10.1016\/j.ijantimicag.2018.12.009_bib0009","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1136\/thx.54.2008.S58","article-title":"The anti-inflammatory effects of macrolides","volume":"54","author":"Wales","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0010","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0011","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0012","first-page":"649570","article-title":"Macrolide therapy in respiratory viral infections","volume":"1","author":"Min","year":"2012","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0013","first-page":"23","article-title":"Treatment of toxoplasmosis in the pregnant mother and newborn child","volume":"84","author":"Straypedersen","year":"1992","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0014","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(94)91928-3","article-title":"Toxoplasmosis in pregnancy","volume":"344","author":"Wallon","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s13238-017-0405-7","article-title":"The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection","volume":"8","author":"Zhang","year":"2017","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0016","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.3390\/v7082841","article-title":"The antiviral effect of baicalin on enterovirus 71 in vitro","volume":"7","author":"Li","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0017","doi-asserted-by":"crossref","first-page":"8976","DOI":"10.1038\/srep08976","article-title":"\u201cRoar\u201d of blaNDM-1 and \u201csilence\u201d of blaOXA-58 co-exist in Acinetobacter pittii","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0018","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1261\/rna.058651.116","article-title":"The eIF3 complex of Trypanosoma brucei: composition conservation does not imply the conservation of structural assembly and subunits function","volume":"23","author":"Li","year":"2017","journal-title":"RNA"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0019","doi-asserted-by":"crossref","first-page":"11915","DOI":"10.1128\/JVI.01207-14","article-title":"Inhibition of enterovirus 71 by adenosine analog NITD008","volume":"88","author":"Deng","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0020","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.antiviral.2012.12.010","article-title":"Development and characterization of a stable eGFP enterovirus 71 for antiviral screening","volume":"97","author":"Shang","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0021","first-page":"183","article-title":"Modification of overlap extension PCR: a mutagenic approach","volume":"8","author":"Patel","year":"2009","journal-title":"Indian J Biotechnol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2017.11.017","article-title":"An evaluation of chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease","volume":"149","author":"Tan","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0023","series-title":"The Expert Committee on the Selection and Use of Essential Medicines Policy, Access and Rational Use","article-title":"Application for inclusion of ribavirin in the WHO model list of essential medicines","year":"2006"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0024","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2174\/1381612043383322","article-title":"The macrolide antibiotics: a pharmacokinetic and pharmacodynamic overview","volume":"10","author":"Jain","year":"2004","journal-title":"Curr Pharm Design"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0025","first-page":"44","article-title":"In vitro study on the effect of ribavirin reducing the EV71 replication","volume":"23","author":"Zhang","year":"2009","journal-title":"Chin J Exp Clin Virol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0026","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1086\/527326","article-title":"Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication","volume":"197","author":"Li","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0027","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","article-title":"In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection","volume":"157","author":"Zhang","year":"2012","journal-title":"Arch Virol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0028","series-title":"The innate anti-viral effects of Azithromycin and other novel macrolides","author":"Porter","year":"2014"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0029","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.3390\/v7122961","article-title":"Innate immunity and immune evasion by Enterovirus 71","volume":"7","author":"Pathinayake","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0030","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1099\/vir.0.81195-0","article-title":"Type I interferons protect mice against enterovirus 71 infection","volume":"86","author":"Liu","year":"2005","journal-title":"J Genl Virol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0031","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3851\/IMP1720","article-title":"Potent inhibition of human enterovirus 71 replication by type I interferon subtypes","volume":"16","author":"Yi","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006625","article-title":"A highly conserved amino acid in VP1 regulates maturation of enterovirus 71","volume":"13","author":"Zhang","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0033","article-title":"Nonstructural protein 2A modulates replication and virulence of Enterovirus 71","volume":"244","author":"Li","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0034","first-page":"9862","article-title":"Enterovirus 71 2B induces cell apoptosis by directly inducing the conformational activation of the proapoptotic protein Bax","volume":"90","author":"Cong","year":"2016","journal-title":"Plos Pathog"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005067","article-title":"Human enterovirus nonstructural protein 2C ATPase functions as both an RNA helicase and ATP-independent RNA chaperone","volume":"11","author":"Xia","year":"2015","journal-title":"Plos Pathog"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0036","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1128\/JVI.65.8.4341-4349.1991","article-title":"Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus","volume":"65","author":"Johnson","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0037","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.71.11.8482-8489.1997","article-title":"Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C","volume":"71","author":"Barton","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.ijantimicag.2018.12.009_bib0038","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11262-014-1035-2","article-title":"A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China","volume":"48","author":"Liu","year":"2014","journal-title":"Virus Genes"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T21:42:24Z","timestamp":1605908544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918303790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0924857918303790"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.009","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}